Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma.

Pönisch, Wolfram

Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma. [electronic resource] - Journal of cancer research and clinical oncology Nov 2014 - 1947-56 p. digital

Publication Type: Journal Article

1432-1335

10.1007/s00432-014-1737-9 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bendamustine Hydrochloride
Boronic Acids--administration & dosage
Bortezomib
Disease-Free Survival
Female
Glomerular Filtration Rate
Humans
Kaplan-Meier Estimate
Leukopenia--chemically induced
Male
Middle Aged
Multiple Myeloma--drug therapy
Nitrogen Mustard Compounds--administration & dosage
Prednisone--administration & dosage
Pyrazines--administration & dosage
Retrospective Studies
Treatment Outcome